# EDGAR Filing Document

**Accession Number:** 0002134313
**File Stem:** 0001628280-26-037388
**Filing Date:** 2026-5
**Character Count:** 7816
**Document Hash:** 121a832add5419bc6022c77160472c6d
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001628280-26-037388.hdr.sgml**: 20260521

**ACCESSION NUMBER**: 0001628280-26-037388

**CONFORMED SUBMISSION TYPE**: 3

**PUBLIC DOCUMENT COUNT**: 1

**CONFORMED PERIOD OF REPORT**: 20260515

**FILED AS OF DATE**: 20260521

**DATE AS OF CHANGE**: 20260521

**REPORTING-OWNER**: 

**OWNER DATA:**
- **COMPANY CONFORMED NAME:** Brown Denny
- **CENTRAL INDEX KEY:** 0002134313

**ORGANIZATION NAME:**

**FILING VALUES:**
- **FORM TYPE:** 3
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 001-38730
- **FILM NUMBER:** 261009934

**MAIL ADDRESS:**
- **ADDRESS IS A NON US LOCATION:** YES
- **STREET 1:** FORGE, 43 CHURCH STREET WEST
- **STREET 2:** C/O LINDE PLC
- **CITY:** WOKING
- **NON US STATE TERRITORY:** SURREY
- **PROVINCE COUNTRY:** X0
- **ZIP:** GU216HT
**ISSUER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** LINDE PLC
- **CENTRAL INDEX KEY:** 0001707925
- **STANDARD INDUSTRIAL CLASSIFICATION:** INDUSTRIAL INORGANIC CHEMICALS [2810]
- **ORGANIZATION NAME:** 08 Industrial Applications and Services
- **EIN:** 000000000
- **STATE OF INCORPORATION:** L2
- **FISCAL YEAR END:** 1231

**BUSINESS ADDRESS:**
- **STREET 1:** FORGE, 43 CHURCH STREET WEST
- **CITY:** WOKING SURREY
- **STATE:** X0
- **ZIP:** GU216HT
- **BUSINESS PHONE:** 00441483242200

**MAIL ADDRESS:**
- **STREET 1:** FORGE, 43 CHURCH STREET WEST
- **CITY:** WOKING SURREY
- **STATE:** X0
- **ZIP:** GU216HT

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** ZAMALIGHT PLC
- **DATE OF NAME CHANGE:** 20170622

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** PRAXAIR
- **DATE OF NAME CHANGE:** 20170614

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** ZAMALIGHT PLC
- **DATE OF NAME CHANGE:** 20170530

### UNITED STATES SECURITIES AND EXCHANGE COMMISSION
**Washington, D.C. 20549**

## FORM 3

### INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

[ ] Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

---

| | | |
|:---|:---|:---|
| **1. Name and Address of Reporting Person**<sup>*</sup><br>Brown Denny<br><sub>(Last) (First) (Middle)</sub><br>C/O LINDE PLC<br>FORGE, 43 CHURCH STREET WEST<br><sub>(Street)</sub><br>WOKING SURREY, UNITED KINGDOM GU216HT<br><sub>(City) (State) (Zip)</sub> | **3. Issuer Name and Ticker or Trading Symbol**<br>LINDE PLC [ LIN ] | **5. If Amendment, Date of Original Filed (Month/Day/Year)**<br>  |
| **2. Date of Event Requiring Statement (Month/Day/Year)**<br>2026-05-15 | **4. Relationship of Reporting Person(s) to Issuer**<br>(Check all applicable)<br>[ ] Director   [ ] 10% Owner<br>[X] Officer (give title below)   [ ] Other (specify below)<br>_VP, Chief Accounting Officer_ | **6. Individual or Joint/Group Filing (Check Applicable Line)**<br>[X] Form filed by One Reporting Person<br>[ ] Form filed by More than One Reporting Person |

---

## Table I - Non-Derivative Securities Beneficially Owned

---

|  |  |  |  |
| --- | --- | --- | --- |
| 1. Title of Security | 2. Amount of Securities Beneficially Owned | 3. Ownership Form | 4. Nature of Indirect Beneficial Ownership |
| Ordinary Shares | 3466.912 | D |  |

---

## Table II - Derivative Securities Beneficially Owned

---

|  |  |  |  |  |  |  |  |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 1. Title of Derivative Security | 2. Date Exercisable and Expiration Date (Month/Day/Year) | 2. Date Exercisable and Expiration Date (Month/Day/Year) | 3. Title and Amount of Underlying Securities | 3. Title and Amount of Underlying Securities | 4. Conversion or Exercise Price | 5. Ownership Form | 6. Nature of Indirect Beneficial Ownership |
| 1. Title of Derivative Security | Date Exercisable | Expiration Date | Title | Amount or Number of Shares | 4. Conversion or Exercise Price | 5. Ownership Form | 6. Nature of Indirect Beneficial Ownership |
| Restricted Stock Units | <sup>(1)</sup> | <sup>(1)</sup> | Ordinary Shares | 247 | <sup>(2)</sup> | D |  |
| Deferred Stock Units | <sup>(3)</sup> | <sup>(3)</sup> | Ordinary Shares | 10.629 | <sup>(2)</sup> | D |  |
| Restricted Stock Units | <sup>(4)</sup> | <sup>(4)</sup> | Ordinary Shares | 235 | <sup>(2)</sup> | D |  |
| Restricted Stock Units | <sup>(5)</sup> | <sup>(5)</sup> | Ordinary Shares | 264 | <sup>(2)</sup> | D |  |
| Stock Options (right to buy) | 2026-03-07<sup>(6)</sup> | 2035-03-07 | Ordinary Shares | 1731 | $468.77 | D |  |
| Stock Options (right to buy) | 2024-03-07<sup>(7)</sup> | 2033-03-07 | Ordinary Shares | 865 | $354.14 | D |  |
| Stock Options (right to buy) | 2023-03-07<sup>(8)</sup> | 2032-03-07 | Ordinary Shares | 1045 | $270.99 | D |  |
| Stock Options (right to buy) | 2022-03-08<sup>(9)</sup> | 2031-03-08 | Ordinary Shares | 1670 | $253.68 | D |  |
| Stock Options (right to buy) | 2027-03-09<sup>(10)</sup> | 2036-03-09 | Ordinary Shares | 2148 | $483.62 | D |  |
| Stock Options (right to buy) | 2019-02-27<sup>(11)</sup> | 2028-02-27 | Ordinary Shares | 5500 | $154 | D |  |
| Stock Options (right to buy) | 2025-03-07<sup>(12)</sup> | 2034-03-07 | Ordinary Shares | 1505 | $465.29 | D |  |
| Stock Options (right to buy) | 2021-03-09<sup>(13)</sup> | 2030-03-09 | Ordinary Shares | 1700 | $173.13 | D |  |
| Stock Options (right to buy) | 2020-03-20<sup>(14)</sup> | 2029-03-20 | Ordinary Shares | 1895 | $176.63 | D |  |

---

### Footnotes:

(1) Restricted Stock Units that will vest in full and payout on or about March 7, 2028 in Linde plc Ordinary Shares on a one-for-one basis.

(2) Conversion to Linde plc Ordinary Shares is on a one-for-one basis.

(3) Deferred stock units acquired under the Linde Compensation Deferral Plan ("Plan"). The deferred stock units will payout in Linde plc Ordinary Share on a one-for-one basis in accordance with the Plan.

(4) Restricted Stock Units that will vest in full and payout on or about March 7, 2027 in Linde plc Ordinary Shares on a one-for-one basis.

(5) Restricted Stock Units that will vest in full and payout on or about March 9, 2029 in Linde plc Ordinary Shares on a one-for-one basis.

(6) This option vests over three years in three consecutive equal annual installments beginning on March 7, 2026.

(7) This option vests over three years in three consecutive equal annual installments beginning on March 7, 2024.

(8) This option vests over three years in three consecutive equal annual installments beginning on March 7, 2023.

(9) This option vests over three years in three consecutive equal annual installments beginning on March 8, 2022.

(10) This option vests over three years in three consecutive equal annual installments beginning on March 9, 2027.

(11) This option vests over three years in three consecutive equal annual installments beginning on February 27, 2019.

(12) This option vests over three years in three consecutive equal annual installments beginning on March 7, 2025.

(13) This option vests over three years in three consecutive equal annual installments beginning on March 9, 2021.

(14) This option vests over three years in three consecutive equal annual installments beginning on March 20, 2020.

**Signature:** Anthony M. Pepper as attorney-in-fact  
**Date:** 2026-05-21

### Remarks:

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.

* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).

** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).

Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.

**Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.**